Login / Signup

Low dose emicizumab prophylaxis in haemophilia a patients: A pilot study from India.

Shweta BansalAnouk A M T DonnersKathelijn FischerKathelijn FischerSavita RangarajanVarsha PhadkeShrutika MhatreBharati SontateMagdelene D' SilvaShahana AnsariShrimati Shetty
Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Keyphrases
  • low dose
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • ejection fraction
  • prognostic factors
  • patient reported